Call to Action - November 23, 2021 - COVID-19 Vaccine: Approval / guidance for children aged five to 11 years, Pfizer / Comirnaty Pediatric Vaccine Administration Education

COVID-19 Vaccine: Approval/guidance for children aged five to ≤ 11 years

On November 19, 2021, Health Canada authorized the PFizer/Comirnaty pediatric COVID-19 vaccine for use in children aged 5 to ≤ 11.  It is expected that there will be sufficient supply available to complete first doses in this pediatric population.  Further information about the pediatric vaccine is available here.

Leads/Directors (or delegates) review and share accordingly.

Pfizer/Comirnaty Pediatric Vaccine Administration Education

In follow-up to the October 29th Admin Update titled: 2021 Immunization Provider and Anaphylaxis Management Self Learning Packages, the training module for Pfizer/Comirnaty Pediatric Vaccine Administration has been added to the page.  The training takes about 30 minutes to complete.

Leads/Directors (or delegates) review and share accordingly.

Info Sharing

Media Releases

COVID-19 Vaccine Bulletins